BiotechnologyMay 14, 20268 min read
Editing the Code of Life: A Physician's View of Gene Therapy
By Dr. Robert Sakulanda

The first time I explained gene therapy to a patient's family, their nine-year-old was in the room. The child had a condition that a decade ago would have been a life sentence. That day, the family was not asking whether the science worked. They were asking whether it was safe, whether it was fair, and whether it was right. Those are the questions I keep coming back to.
A short, honest history
Gene editing is not a metaphor; it is molecular precision. Systems like CRISPR give scientists something previous generations of physicians could only dream of — the ability to find a specific sequence of DNA and change it. Sickle cell disease, certain inherited blindesses, some cancers: conditions once managed forever are now, in specific cases, genuinely corrected.
But precision at the molecular level does not remove uncertainty at the human level. A therapy that works in a trial population must still travel the long road to real clinics, real budgets, real communities.
What I tell patients and families
After years split between wards and graduate study in biotechnology, here is the honest version I give:
- What it can do: in carefully selected conditions, gene-based therapies can change the arc of a disease rather than merely slow it.
- What it cannot do: rewrite everything, fix every mutation, or deliver outcomes without trade-offs that must be weighed carefully.
- What it costs: not only in dollars — access, equity, and the trust of communities that medicine has failed before all shape whether a breakthrough reaches the people it was built for.
The measure of a technology is not what it makes possible. It is what it makes reachable.
Why the storyteller matters
Medicine has learned, more than once, that a therapy without trust fails. Trust is not built in laboratories; it is built in conversations — at bedsides, in churches and community halls, in honest articles that neither hype nor dismiss.
That is where I try to stand when I write about biotechnology: close enough to the science to describe it truthfully, close enough to the patient to describe it humanely. The code of life is being edited, letter by letter. The story of how we use it is still being written — by all of us.
Published May 14, 2026
Keep reading
All articlesBiotechnology
From Bedside to Bench: Why Medicine Needs Biotechnology
After two decades of practicing medicine, I went back to school to study biotechnology. The two worlds speak different languages — and patients need us to be fluent in both.
Entrepreneurship
Why a Physician Bought a Football Club
In 2017 I bought Nkwiza FC, a small club in Zambia's Copperbelt, and rebuilt it as Mufulira United. People asked why a doctor in America wanted a football team. The answer has everything to do with health.

